Private Placement

With a key FAA filing, Electra's hybrid-electric EL9 moves closer to reality, promising to bypass airports with 150-foot takeoffs and landings.

A CFO's $30k stock purchase is more than a headline. It's part of a pattern of insider confidence at JFB, signaling a bullish outlook.

As Sharebite brings its meal platform to the UK, it’s not just about perks. It’s a strategic play for productivity, retention, and the future of work.

Glean's new research institute and context-aware agents offer a pragmatic path for businesses struggling to operationalize AI safely and effectively.

A record 102,835 donors raised $56.5 million for Colorado Gives Day, showcasing a powerful philanthropic response amid economic uncertainty.

Condor Energies secures $10M in a high-stakes financing to fast-track its Uzbekistan gas program. A deep dive into the strategy, risks, and what it means.

CEO Adrian Mendes' major buy-in signals deep confidence as Perimeter Medical AI navigates FDA approval for its game-changing cancer surgery technology.

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

A Chinese firm's entry into Germany's EV market seems distant from medicine, but its tricycle vehicle could be the key to a greener, faster last-mile for healthcare.

After a major turnaround, playable media firm Super League is betting its future on digital assets, bringing in heavyweights to lead its charge into Web3.

Hapag-Lloyd renews a key $550M funding facility, revealing a critical strategy for financial resilience in the turbulent global shipping industry.

A new narcolepsy drug could finally offer patients what they've been missing: a single nightly dose with low sodium, transforming lives and the market.

Clene Inc. heads to an investor conference with powerful new ALS data. But with a limited cash runway, the real test is securing market confidence.

After a financial tightrope walk, Actelis Networks is back in Nasdaq's good graces. But the real story is its mission to secure our future's IoT.

JFB Construction's CEO just invested $100k of his own money in company stock. We dive into the projects and market trends fueling this bold move.

With validated Phase 1b data, ONL Therapeutics' novel drug aims to protect vision cells, not just slow disease, in a challenge to current GA therapies.

Once mired in debt, Castellum has secured over $170M in prime contracts, signaling a dramatic resurgence in the competitive federal defense market.

Beyond the press release: How two strategic hires signal Plus Therapeutics' aggressive push to commercialize its CNSide platform and capture a $6B market.

With a critical $1.74M lifeline, Northstar Clean Technologies is racing to prove its shingle recycling tech can be a profitable circular economy champion.